Should diabetic patients be asked to test their blood glucose 90 to 120 minutes after the beginning of their meals?

Diabetes and Metabolism

Volumn 32, Issue 4, 2006, Pages 377-381

  Sachon, C ^a   Jacqueminet, S ^a   Hartemann Heurtier, A ^a   Grimaldi, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiovascular risk; Fasting glycaemia; Glycated haemoglobin; Post prandial hyperglycaemia; Pregnancy; Self blood glucose control

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; TRIACYLGLYCEROL;

BLOOD EXAMINATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETIC PATIENT; DIET RESTRICTION; EPIDEMIOLOGICAL DATA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; MACROSOMIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PREDICTION; PREGNANCY DIABETES MELLITUS; PRESCRIPTION; REVIEW; SELF MONITORING; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33748790681     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70295-1     Document Type: Article

References (30)

1. Freinkel N. Gestational diabetes 1979: philosophical practical aspects of a major public health problem. Diabetes Care 1980;3:399-401.
2. De Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-41.
3. Langer O, Conway DL, Berkus MD, Xenakis EMJ, Gonzalez O. A comparison of Glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
4. Ciangura C, Jacqueminet S, Pousset M, et al. Diabète gestationnel: suivi de 142 grossesses. Diabetes Metab 2006;32:S79(abstract).
5. The DECODE study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999;354:617-21.
6. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95.783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
7. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 2002;45:461-75.
8. Hanefeld M, Fischer S, Julius U, et al. The DIS Group. Risk factor for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow up. Diabetologia 1996;39: 1577-83.
9. Balkau B, Forhan A, Esch wege E. Two-hour plasma glucose is not unequivocally predictive for early death in men impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 2002;45:1224-30.
10. Ceriello A. Postprandial hyperglycemia and diabetes complications. Is it time to treat? Diabetes 2005;54:1-7.
11. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized cross-over study. J Clin Endocrinol Metab 2006;91:837-42.
12. Hanefeld M, Chiasson JL, Koelher C, Henkel E, Shaper F, Temelkova-Kurktshiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance Stroke 2004;35:1073-8.
13. Fava D, Cassone-Faldetta M, Laurenti O, De Luca O, Ghiselli A, De Mattia G. Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilatation in type 2 diabetes. Diabet Med 2002;19:752-7.
14. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia ion endothelial dysfunction and oxidative stress generation. Effects of short and long-term simvastatin treatment. Circulation 2002;106:1211-8.
15. Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005;111:2518-24.
16. The Diabetes Control and Complications Trial. Epidemiology of Diabetes Interventions and Complications (DCCT: EDIC) Study Research Group Intensive Diabetes Treatment and Cardiovascular Disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
17. Temelkova-Kurktschiev T, Koehler C, Shaper F, et al. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 1998;41:706-12.
18. Esposito K, Giugliano D, Nappo F, Marfella R. for the Campanian Postprandial Hyperglycemia Study Group Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004;110:214-9.
19. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. for the STOP-NIDDM Trial Research Group Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial JAMA 2003;290:486-94.
20. Kaiser T, Sawicki PT. Acarbose for prevention of diabetes, hypertension and cardiovascular events? a critical analysis of the STOP-NIDDM data. Diabetologia 2004;47:575-80.
21. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycaemia mean? Diabet Med 2004;21:208-13.
22. Schichiri M, Ohkubo Y, Kishikawa H, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23:B21-B29.
23. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
24. Monnier L, Benichou M, Charra-Ebrard S, Boegner C, Colette C. An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives. Diabetes Metab 2005;31:101-9.
25. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA. Postprandial hyperglycemia in patients with non insulin-dependent diabetes mellitus. J Clin Invest 1986;77:1 525-32.
26. Gin H, Rigalleau V. Post-prandial hyperglycemia. Post-prandial hyperglycemia and diabetes. Diabetes Metab 2000;26:265-72.
27. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance. A re-examination. Diabetes 2000;49:677-83.
28. Monnier L, Lapinski H, Colette C. Contributions of fasting and post-prandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003;26:881-5.
29. Holman RR, Turner RC, Cull CA. on behalf of the UKPDS Study Group A randomized double-blind trial of acarbose in the type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 1999;22:960-4.
30. Monnier L, Colette C. Should seven be the magic number of type 2 diabetes? Diabetologia 2005;48:1943-4.